1Rs 7,744 Crore A Year: Indian-Origin CEO Highest-Paid Executive After Musk maheshmakwanazotac@gmail.comJune 27, 2026
2Sellas Life Sciences options trading jumps to 66,504 contracts maheshmakwanazotac@gmail.comJune 27, 2026
3Weak monsoon emerges as India’s next economic problem after crude oil maheshmakwanazotac@gmail.comJune 27, 2026
BusinessEnglish The Rs 12,000 Crore Race for GLP-1 Drugs: Impact on India’s Obesity Crisis maheshmakwanazotac@gmail.comMarch 25, 20260 India is witnessing a surge in demand for GLP-1 drugs, potentially transforming obesity treatment while raising regulatory concerns.